Appointment of M/s SBR & Co. LLP, Company Secretaries (LLP No. AA0-9057) as Secretarial auditors of the company for the FY 2025-2030.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Genomic Valley Biotech's board met on 7th August 2025 and approved several items. The company reported un-audited financial results for Q1 FY26 (quarter ended 30 June 2025), with a profit of Rs. 2.47 lakh and basic EPS of Rs. 0.08. SBR & Co. LLP, a Navi Mumbai-based firm of Company Secretaries with 6+ years of experience, was appointed as Secretarial Auditor for a 5-year term covering FY 2025-2030. Mr. Navjyoti Kumar Jha (25 years of experience) was appointed as Internal Auditor for FY 2025-26. Mr. Yogesh Agrawal (62), a promoter and Chartered Accountant with 35 years of experience, was re-appointed as Chairman & Managing Director for another 5 years effective 7 September 2025.
The re-appointment of the existing promoter-CMD provides leadership continuity, while the fresh appointment of secretarial and internal auditors strengthens the governance and compliance framework. Q1 results show only marginal profit, indicating the company remains in a small-scale operating phase with limited near-term share price catalysts.